Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Completed Phase 4 Trials for Flu caused by Influenza Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT03023683Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)
NCT03022435T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012
NCT03020498B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)
NCT03028974Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)
NCT03023553The Human Mucosal Immune Responses to Influenza Virus (SLVP026)
NCT02141581Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)
NCT02133781B-cell Immunity to Influenza (SLVP017)- Year 1, 2009
NCT01987349T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009